Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H3 | Q13133 | 10/20 | 1.00 |
| ▸ | NR1H2 | P55055 | 6/20 | 1.00 |
| ▸ | PPARA | Q07869 | 2/20 | 0.49 |
| ▸ | ALPL | P05186 | 1/20 | 0.49 |
| ▸ | PPARD | Q03181 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | ALDH2 | P05091 | 2/20 | 0.49 |
| ▸ | ALDH3A1 | P30838 | 2/20 | 0.49 |
| ▸ | PARK7 | Q99497 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29616419 | 1.00 | NR1H3 (1.00) | NR1H3NR1H2PPARAALPLPPARD | |
| SCHEMBL1904159 | 0.81 | NR1H3 (0.68) | NR1H3NR1H2ALDH1A1POLB | |
| SCHEMBL11337352 | 0.80 | NR1H3 (0.67) | NR1H3NR1H2PPARAPPARDALDH1A1 | |
| SCHEMBL27586782 | 0.80 | NR1H3 (0.70) | NR1H3NR1H2PKMPOLB | |
| SCHEMBL5717701 | 0.78 | NR1H3 (0.63) | NR1H3NR1H2PPARAPPARDALDH1A1 | |
| SCHEMBL6792489 | 0.77 | NR1H3 (0.62) | NR1H3NR1H2POLB | |
| SCHEMBL9665968 | 0.77 | NR1H2 (0.62) | NR1H3NR1H2POLB | |
| SCHEMBL31261698 | 0.77 | NR1H3 (0.62) | NR1H3NR1H2POLB | |
| SCHEMBL6690679 | 0.76 | NR1H3 (0.61) | NR1H3NR1H2PPARAPPARDALDH1A1 | |
| SCHEMBL29378620 | 0.76 | NR1H3 (1.00) | NR1H3NR1H2ALDH1A1ALDH2ALDH3A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3177621-B1 | NOVEL HDAC6 INHIBITORS AND THEIR USES | UNIV REGENSBURG (DE) | 2021-11-10 | — | — | EP | disclosed |
| US-10106540-B2 | HDAC6 inhibitors and their uses | UNIVERSITÄT REGENSBURG (DE) | 2018-10-23 | — | — | US | disclosed |
| EP-2547696-B1 | FRAGMENTS OF THE PA SUBUNIT OF RNA DEPENDENT RNA POLYMERASE FROM PANDEMIC INFLUENZA VIRUS A 2009 H1N1, AND THEIR USE | EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL (DE) | 2018-05-23 | — | — | EP | disclosed |
| US-20180044649-A1 | INFLUENZA A 2009 PANDEMIC H1N1 POLYPEPTIDE FRAGMENTS COMPRISING ENDONUCLEASE ACTIVITY AND THEIR USE | EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL (DE) | 2018-02-15 | — | — | US | disclosed |
| US-9783794-B2 | Influenza A 2009 pandemic H1N1 polypeptide fragments comprising endonuclease activity and their use | EUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL) (DE) | 2017-10-10 | — | — | US | disclosed |
| US-20170210743-A1 | NOVEL HDAC6 INHIBITORS AND THEIR USES | Universitätsklinikum Jena (DE) | 2017-07-27 | — | — | US | disclosed |
| EP-3177621-A1 | NOVEL HDAC6 INHIBITORS AND THEIR USES | Universität Regensburg (DE) | 2017-06-14 | — | — | EP | disclosed |
| US-20160053241-A1 | INFLUENZA A 2009 PANDEMIC H1N1 POLYPEPTIDE FRAGMENTS COMPRISING ENDONUCLEASE ACTIVITY AND THEIR USE | EUROPEAN MOLECULAR BIOLOGY LABORATORY (DE) | 2016-02-25 | — | — | US | disclosed |
| WO-2016020369-A1 | NOVEL HDAC6 INHIBITORS AND THEIR USES | UNIVERSITÄT REGENSBURG (DE) | 2016-02-11 | — | — | WO | disclosed |
| US-9181307-B2 | Influenza A 2009 pandemic H1N1 polypeptide fragments comprising endonuclease activity and their use | EUROPEAN MOLECULAR BIOLOGY LABORATORY (DE) | 2015-11-10 | — | — | US | disclosed |
| US-20130023565-A1 | INFLUENZA A 2009 PANDEMIC H1N1 POLYPEPTIDE FRAGMENTS COMPRISING ENDONUCLEASE ACTIVITY AND THEIR USE | EUROPEAN MOLECULAR BIOLOGY LABORATORY (DE) | 2013-01-24 | — | — | US | disclosed |
| EP-2547696-A2 | FRAGMENTS OF THE PA SUBUNIT OF RNA DEPENDENT RNA POLYMERASE FROM PANDEMIC INFLUENZA VIRUS A 2009 H1N1, AND THEIR USE | EUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL) (DE) | 2013-01-23 | — | — | EP | disclosed |
| WO-2011113579-A2 | INFLUENZA A 2009 PANDEMIC H1N1 POLYPEPTIDE FRAGMENTS COMPRISING ENDONUCLEASE ACTIVITY AND THEIR USE | EUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL) (DE) | 2011-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130023565-A1 | INFLUENZA A 2009 PANDEMIC H1N1 POLYPEPTIDE FRAGMENTS COMPRISING ENDONUCLEASE ACTIVITY AND THEIR USE | RNASE1, RNASEH1, MME | NR1H3 4267/4885NR1H2 4287/4885PPARA 519/4885 |
| US-20170210743-A1 | NOVEL HDAC6 INHIBITORS AND THEIR USES | HDAC6, HDAC5, HDAC4 | NR1H3 1653/4885NR1H2 1674/4885PPARA 3802/4885 |
| US-20160053241-A1 | INFLUENZA A 2009 PANDEMIC H1N1 POLYPEPTIDE FRAGMENTS COMPRISING ENDONUCLEASE ACTIVITY AND THEIR USE | RNASE1, ACE, RNASEH1 | NR1H3 4375/4885NR1H2 4528/4885PPARA 446/4885 |
| US-10106540-B2 | HDAC6 inhibitors and their uses | HDAC6, HDAC5, HDAC4 | NR1H3 1270/4885NR1H2 1255/4885PPARA 3102/4885 |
| US-20180044649-A1 | INFLUENZA A 2009 PANDEMIC H1N1 POLYPEPTIDE FRAGMENTS COMPRISING ENDONUCLEASE ACTIVITY AND THEIR USE | RNASE1, ACE, RNASEH1 | NR1H3 4375/4885NR1H2 4528/4885PPARA 446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.